{"id":31036,"date":"2025-05-29T15:55:55","date_gmt":"2025-05-29T20:55:55","guid":{"rendered":"https:\/\/myeloma.ca\/?p=31036"},"modified":"2025-05-29T15:57:41","modified_gmt":"2025-05-29T20:57:41","slug":"derniere-recherche-sur-le-myelome","status":"publish","type":"post","link":"https:\/\/myeloma.ca\/fr\/2025\/05\/29\/derniere-recherche-sur-le-myelome\/","title":{"rendered":"Derni\u00e8re recherche sur le my\u00e9lome"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.mdpi.com\/1718-7729\/32\/4\/238\"><em>Perspectives on Outpatient Delivery of Bispecific T-Cell Engager Therapies for Multiple Myeloma<\/em><\/a> [Perspectives sur l\u2019administration en milieu ambulatoire des anticorps bisp\u00e9cifiques ciblant les cellules T dans le traitement du my\u00e9lome multiple] (en anglais).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Ces recommandations d\u2019experts ont \u00e9t\u00e9 d\u00e9velopp\u00e9es pour aider les cliniciens \u00e0 mieux suivre les patients recevant des traitements \u00e0 base d\u2019anticorps bisp\u00e9cifiques ciblant les cellules T (p. ex., des agents tels que teclistamab et elranatamab) et pour soutenir les \u00e9tablissements dans la mise en place de protocoles facilitant leur administration en milieu ambulatoire.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Perspectives on Outpatient Delivery of Bispecific T-Cell Engager Therapies for Multiple Myeloma [Perspectives sur l\u2019administration en milieu ambulatoire des anticorps bisp\u00e9cifiques ciblant les cellules T dans le traitement du my\u00e9lome multiple] (en anglais). Ces recommandations d\u2019experts ont \u00e9t\u00e9 d\u00e9velopp\u00e9es pour aider les cliniciens \u00e0 mieux suivre les patients recevant des traitements \u00e0 base d\u2019anticorps bisp\u00e9cifiques [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_members_access_role":[],"_members_access_error":""},"categories":[88,53],"tags":[],"class_list":["post-31036","post","type-post","status-publish","format-standard","hentry","category-actualites","category-actualites-et-evenement"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.0.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"Perspectives on Outpatient Delivery of Bispecific T-Cell Engager Therapies for Multiple Myeloma [Perspectives sur l\u2019administration en milieu ambulatoire des anticorps bisp\u00e9cifiques ciblant les cellules T dans le traitement du my\u00e9lome multiple] (en anglais). Ces recommandations d\u2019experts ont \u00e9t\u00e9 d\u00e9velopp\u00e9es pour aider les cliniciens \u00e0 mieux suivre les patients recevant des traitements \u00e0 base d\u2019anticorps bisp\u00e9cifiques\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Leigh Kinch-Pedrosa\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/myeloma.ca\/fr\/2025\/05\/29\/derniere-recherche-sur-le-myelome\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.0.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"fr_FR\" \/>\n\t\t<meta property=\"og:site_name\" content=\"My\u00e9lome Canada |\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Derni\u00e8re recherche sur le my\u00e9lome | My\u00e9lome Canada\" \/>\n\t\t<meta property=\"og:description\" content=\"Perspectives on Outpatient Delivery of Bispecific T-Cell Engager Therapies for Multiple Myeloma [Perspectives sur l\u2019administration en milieu ambulatoire des anticorps bisp\u00e9cifiques ciblant les cellules T dans le traitement du my\u00e9lome multiple] (en anglais). Ces recommandations d\u2019experts ont \u00e9t\u00e9 d\u00e9velopp\u00e9es pour aider les cliniciens \u00e0 mieux suivre les patients recevant des traitements \u00e0 base d\u2019anticorps bisp\u00e9cifiques\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/myeloma.ca\/fr\/2025\/05\/29\/derniere-recherche-sur-le-myelome\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2025-05-29T20:55:55+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2025-05-29T20:57:41+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Derni\u00e8re recherche sur le my\u00e9lome | My\u00e9lome Canada\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Perspectives on Outpatient Delivery of Bispecific T-Cell Engager Therapies for Multiple Myeloma [Perspectives sur l\u2019administration en milieu ambulatoire des anticorps bisp\u00e9cifiques ciblant les cellules T dans le traitement du my\u00e9lome multiple] (en anglais). Ces recommandations d\u2019experts ont \u00e9t\u00e9 d\u00e9velopp\u00e9es pour aider les cliniciens \u00e0 mieux suivre les patients recevant des traitements \u00e0 base d\u2019anticorps bisp\u00e9cifiques\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2025\\\/05\\\/29\\\/derniere-recherche-sur-le-myelome\\\/#blogposting\",\"name\":\"Derni\\u00e8re recherche sur le my\\u00e9lome | My\\u00e9lome Canada\",\"headline\":\"Derni\\u00e8re recherche sur le my\\u00e9lome\",\"author\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/leigh-kp\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/stage.myeloma.ca\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo_en.png\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#articleImage\"},\"datePublished\":\"2025-05-29T15:55:55-05:00\",\"dateModified\":\"2025-05-29T15:57:41-05:00\",\"inLanguage\":\"fr-FR\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2025\\\/05\\\/29\\\/derniere-recherche-sur-le-myelome\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2025\\\/05\\\/29\\\/derniere-recherche-sur-le-myelome\\\/#webpage\"},\"articleSection\":\"Actualit\\u00e9s, Actualit\\u00e9s et \\u00e9v\\u00e9nement\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2025\\\/05\\\/29\\\/derniere-recherche-sur-le-myelome\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#listItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/#listItem\",\"name\":\"Actualit\\u00e9s et \\u00e9v\\u00e9nement\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/#listItem\",\"position\":2,\"name\":\"Actualit\\u00e9s et \\u00e9v\\u00e9nement\",\"item\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/actualites\\\/#listItem\",\"name\":\"Actualit\\u00e9s\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#listItem\",\"name\":\"Accueil\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/actualites\\\/#listItem\",\"position\":3,\"name\":\"Actualit\\u00e9s\",\"item\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/actualites\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2025\\\/05\\\/29\\\/derniere-recherche-sur-le-myelome\\\/#listItem\",\"name\":\"Derni\\u00e8re recherche sur le my\\u00e9lome\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/#listItem\",\"name\":\"Actualit\\u00e9s et \\u00e9v\\u00e9nement\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2025\\\/05\\\/29\\\/derniere-recherche-sur-le-myelome\\\/#listItem\",\"position\":4,\"name\":\"Derni\\u00e8re recherche sur le my\\u00e9lome\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/category\\\/actualites-et-evenement\\\/actualites\\\/#listItem\",\"name\":\"Actualit\\u00e9s\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#organization\",\"name\":\"Myeloma Canada\",\"url\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/\",\"telephone\":\"+18887985771\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/stage.myeloma.ca\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo_en.png\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2025\\\/05\\\/29\\\/derniere-recherche-sur-le-myelome\\\/#organizationLogo\"},\"image\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2025\\\/05\\\/29\\\/derniere-recherche-sur-le-myelome\\\/#organizationLogo\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/leigh-kp\\\/#author\",\"url\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/leigh-kp\\\/\",\"name\":\"Leigh Kinch-Pedrosa\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2025\\\/05\\\/29\\\/derniere-recherche-sur-le-myelome\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bc9a857bcf898667f0e3d913441f25e1d2d9d652d14911323fd2e018121c78a3?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"Leigh Kinch-Pedrosa\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2025\\\/05\\\/29\\\/derniere-recherche-sur-le-myelome\\\/#webpage\",\"url\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2025\\\/05\\\/29\\\/derniere-recherche-sur-le-myelome\\\/\",\"name\":\"Derni\\u00e8re recherche sur le my\\u00e9lome | My\\u00e9lome Canada\",\"description\":\"Perspectives on Outpatient Delivery of Bispecific T-Cell Engager Therapies for Multiple Myeloma [Perspectives sur l\\u2019administration en milieu ambulatoire des anticorps bisp\\u00e9cifiques ciblant les cellules T dans le traitement du my\\u00e9lome multiple] (en anglais). Ces recommandations d\\u2019experts ont \\u00e9t\\u00e9 d\\u00e9velopp\\u00e9es pour aider les cliniciens \\u00e0 mieux suivre les patients recevant des traitements \\u00e0 base d\\u2019anticorps bisp\\u00e9cifiques\",\"inLanguage\":\"fr-FR\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/2025\\\/05\\\/29\\\/derniere-recherche-sur-le-myelome\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/leigh-kp\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/author\\\/leigh-kp\\\/#author\"},\"datePublished\":\"2025-05-29T15:55:55-05:00\",\"dateModified\":\"2025-05-29T15:57:41-05:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/\",\"name\":\"Myeloma Canada\",\"inLanguage\":\"fr-FR\",\"publisher\":{\"@id\":\"https:\\\/\\\/myeloma.ca\\\/fr\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Derni\u00e8re recherche sur le my\u00e9lome | My\u00e9lome Canada","description":"Perspectives on Outpatient Delivery of Bispecific T-Cell Engager Therapies for Multiple Myeloma [Perspectives sur l\u2019administration en milieu ambulatoire des anticorps bisp\u00e9cifiques ciblant les cellules T dans le traitement du my\u00e9lome multiple] (en anglais). Ces recommandations d\u2019experts ont \u00e9t\u00e9 d\u00e9velopp\u00e9es pour aider les cliniciens \u00e0 mieux suivre les patients recevant des traitements \u00e0 base d\u2019anticorps bisp\u00e9cifiques","canonical_url":"https:\/\/myeloma.ca\/fr\/2025\/05\/29\/derniere-recherche-sur-le-myelome\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/myeloma.ca\/fr\/2025\/05\/29\/derniere-recherche-sur-le-myelome\/#blogposting","name":"Derni\u00e8re recherche sur le my\u00e9lome | My\u00e9lome Canada","headline":"Derni\u00e8re recherche sur le my\u00e9lome","author":{"@id":"https:\/\/myeloma.ca\/fr\/author\/leigh-kp\/#author"},"publisher":{"@id":"https:\/\/myeloma.ca\/fr\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/stage.myeloma.ca\/wp-content\/uploads\/2023\/02\/logo_en.png","@id":"https:\/\/myeloma.ca\/fr\/#articleImage"},"datePublished":"2025-05-29T15:55:55-05:00","dateModified":"2025-05-29T15:57:41-05:00","inLanguage":"fr-FR","mainEntityOfPage":{"@id":"https:\/\/myeloma.ca\/fr\/2025\/05\/29\/derniere-recherche-sur-le-myelome\/#webpage"},"isPartOf":{"@id":"https:\/\/myeloma.ca\/fr\/2025\/05\/29\/derniere-recherche-sur-le-myelome\/#webpage"},"articleSection":"Actualit\u00e9s, Actualit\u00e9s et \u00e9v\u00e9nement"},{"@type":"BreadcrumbList","@id":"https:\/\/myeloma.ca\/fr\/2025\/05\/29\/derniere-recherche-sur-le-myelome\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/#listItem","position":1,"name":"Accueil","item":"https:\/\/myeloma.ca\/fr\/","nextItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/#listItem","name":"Actualit\u00e9s et \u00e9v\u00e9nement"}},{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/#listItem","position":2,"name":"Actualit\u00e9s et \u00e9v\u00e9nement","item":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/","nextItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/actualites\/#listItem","name":"Actualit\u00e9s"},"previousItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/#listItem","name":"Accueil"}},{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/actualites\/#listItem","position":3,"name":"Actualit\u00e9s","item":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/actualites\/","nextItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/2025\/05\/29\/derniere-recherche-sur-le-myelome\/#listItem","name":"Derni\u00e8re recherche sur le my\u00e9lome"},"previousItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/#listItem","name":"Actualit\u00e9s et \u00e9v\u00e9nement"}},{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/2025\/05\/29\/derniere-recherche-sur-le-myelome\/#listItem","position":4,"name":"Derni\u00e8re recherche sur le my\u00e9lome","previousItem":{"@type":"ListItem","@id":"https:\/\/myeloma.ca\/fr\/category\/actualites-et-evenement\/actualites\/#listItem","name":"Actualit\u00e9s"}}]},{"@type":"Organization","@id":"https:\/\/myeloma.ca\/fr\/#organization","name":"Myeloma Canada","url":"https:\/\/myeloma.ca\/fr\/","telephone":"+18887985771","logo":{"@type":"ImageObject","url":"https:\/\/stage.myeloma.ca\/wp-content\/uploads\/2023\/02\/logo_en.png","@id":"https:\/\/myeloma.ca\/fr\/2025\/05\/29\/derniere-recherche-sur-le-myelome\/#organizationLogo"},"image":{"@id":"https:\/\/myeloma.ca\/fr\/2025\/05\/29\/derniere-recherche-sur-le-myelome\/#organizationLogo"}},{"@type":"Person","@id":"https:\/\/myeloma.ca\/fr\/author\/leigh-kp\/#author","url":"https:\/\/myeloma.ca\/fr\/author\/leigh-kp\/","name":"Leigh Kinch-Pedrosa","image":{"@type":"ImageObject","@id":"https:\/\/myeloma.ca\/fr\/2025\/05\/29\/derniere-recherche-sur-le-myelome\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/bc9a857bcf898667f0e3d913441f25e1d2d9d652d14911323fd2e018121c78a3?s=96&d=mm&r=g","width":96,"height":96,"caption":"Leigh Kinch-Pedrosa"}},{"@type":"WebPage","@id":"https:\/\/myeloma.ca\/fr\/2025\/05\/29\/derniere-recherche-sur-le-myelome\/#webpage","url":"https:\/\/myeloma.ca\/fr\/2025\/05\/29\/derniere-recherche-sur-le-myelome\/","name":"Derni\u00e8re recherche sur le my\u00e9lome | My\u00e9lome Canada","description":"Perspectives on Outpatient Delivery of Bispecific T-Cell Engager Therapies for Multiple Myeloma [Perspectives sur l\u2019administration en milieu ambulatoire des anticorps bisp\u00e9cifiques ciblant les cellules T dans le traitement du my\u00e9lome multiple] (en anglais). Ces recommandations d\u2019experts ont \u00e9t\u00e9 d\u00e9velopp\u00e9es pour aider les cliniciens \u00e0 mieux suivre les patients recevant des traitements \u00e0 base d\u2019anticorps bisp\u00e9cifiques","inLanguage":"fr-FR","isPartOf":{"@id":"https:\/\/myeloma.ca\/fr\/#website"},"breadcrumb":{"@id":"https:\/\/myeloma.ca\/fr\/2025\/05\/29\/derniere-recherche-sur-le-myelome\/#breadcrumblist"},"author":{"@id":"https:\/\/myeloma.ca\/fr\/author\/leigh-kp\/#author"},"creator":{"@id":"https:\/\/myeloma.ca\/fr\/author\/leigh-kp\/#author"},"datePublished":"2025-05-29T15:55:55-05:00","dateModified":"2025-05-29T15:57:41-05:00"},{"@type":"WebSite","@id":"https:\/\/myeloma.ca\/fr\/#website","url":"https:\/\/myeloma.ca\/fr\/","name":"Myeloma Canada","inLanguage":"fr-FR","publisher":{"@id":"https:\/\/myeloma.ca\/fr\/#organization"}}]},"og:locale":"fr_FR","og:site_name":"My\u00e9lome Canada |","og:type":"article","og:title":"Derni\u00e8re recherche sur le my\u00e9lome | My\u00e9lome Canada","og:description":"Perspectives on Outpatient Delivery of Bispecific T-Cell Engager Therapies for Multiple Myeloma [Perspectives sur l\u2019administration en milieu ambulatoire des anticorps bisp\u00e9cifiques ciblant les cellules T dans le traitement du my\u00e9lome multiple] (en anglais). Ces recommandations d\u2019experts ont \u00e9t\u00e9 d\u00e9velopp\u00e9es pour aider les cliniciens \u00e0 mieux suivre les patients recevant des traitements \u00e0 base d\u2019anticorps bisp\u00e9cifiques","og:url":"https:\/\/myeloma.ca\/fr\/2025\/05\/29\/derniere-recherche-sur-le-myelome\/","article:published_time":"2025-05-29T20:55:55+00:00","article:modified_time":"2025-05-29T20:57:41+00:00","twitter:card":"summary_large_image","twitter:title":"Derni\u00e8re recherche sur le my\u00e9lome | My\u00e9lome Canada","twitter:description":"Perspectives on Outpatient Delivery of Bispecific T-Cell Engager Therapies for Multiple Myeloma [Perspectives sur l\u2019administration en milieu ambulatoire des anticorps bisp\u00e9cifiques ciblant les cellules T dans le traitement du my\u00e9lome multiple] (en anglais). Ces recommandations d\u2019experts ont \u00e9t\u00e9 d\u00e9velopp\u00e9es pour aider les cliniciens \u00e0 mieux suivre les patients recevant des traitements \u00e0 base d\u2019anticorps bisp\u00e9cifiques"},"aioseo_meta_data":{"post_id":"31036","title":null,"description":null,"keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2026-04-30 08:53:04","updated":"2026-04-30 08:53:04","seo_analyzer_scan_date":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"_links":{"self":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/31036","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/comments?post=31036"}],"version-history":[{"count":1,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/31036\/revisions"}],"predecessor-version":[{"id":31037,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/31036\/revisions\/31037"}],"wp:attachment":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/media?parent=31036"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/categories?post=31036"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/tags?post=31036"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}